Cardiac POC Testing Devices Market Size, Share, Trends, Growth Outlook

Cardiac POC Testing Devices Market is estimated to increase at a growth rate of 6.1% CAGR over the forecast period from 2024 to 2030.

The global Cardiac POC Testing Devices Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Cardiac Markers Test (Cardiac Troponin (cTn) Test, Myoglobin Test, Creatine Kinase MB Isoenzyme (CK-MB) Test, Combinational Test Kits, Brain Natriuretic Peptide (BNP) Test, Analyzers), By End-User (Hospitals, Diagnostic Laboratories, Others).

An Introduction to Cardiac POC Testing Devices Market in 2024

The Cardiac Point-of-Care (POC) Testing Devices Market comprises rapid diagnostic tests and handheld devices used for immediate assessment of cardiac biomarkers, enzymes, and electrolytes at the point of care, such as emergency departments, clinics, and ambulances. POC testing devices include handheld analyzers, cartridges, and strips for troponin, B-type natriuretic peptide (BNP), and glucose monitoring, facilitating rapid diagnosis, triage, and treatment decisions in cardiac emergencies. In 2024, this market addresses portable POC platforms, connectivity solutions, and integrated diagnostic panels for timely and accurate cardiac testing, improving patient outcomes and healthcare efficiency.

Cardiac POC Testing Devices Market Competitive Landscape

The global Cardiac POC Testing Devices Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Cardiac POC Testing Devices Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Cardiac POC Testing Devices Industry include- Abbott Laboratories, ACON Laboratories Inc, Alfa Scientific Designs Inc, American Screening Corp Inc, Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Nano-Ditech Corp, Nova Biomedical Corp, Siemens Healthineers AG.

Cardiac POC Testing Devices Market Trend: Shift Towards Point-of-Care Testing (POCT)

One prominent trend in the Cardiac POC Testing Devices market is the increasing adoption of point-of-care testing (POCT) for cardiac biomarkers. POCT devices enable rapid and convenient testing of cardiac biomarkers such as troponin, B-type natriuretic peptide (BNP), and D-dimer directly at the patient's bedside or in outpatient settings. This trend is driven by the need for timely diagnosis and management of acute cardiac conditions, such as myocardial infarction and heart failure, where quick decision-making is crucial for patient outcomes. The shift towards POCT offers healthcare providers the ability to obtain actionable diagnostic results rapidly, facilitating timely interventions and improving patient care.

Cardiac POC Testing Devices Market Driver: Growing Demand for Rapid Diagnostic Solutions

A key driver for the Cardiac POC Testing Devices market is the growing demand for rapid diagnostic solutions in cardiology. With the increasing prevalence of cardiovascular diseases and the rising burden on healthcare systems, there is a heightened need for efficient and accurate diagnostic tools to support early detection, risk stratification, and monitoring of cardiac conditions. Cardiac POC testing devices address this demand by providing on-the-spot testing for cardiac biomarkers, allowing healthcare providers to make timely treatment decisions, reduce patient wait times, and optimize resource utilization. The emphasis on improving patient outcomes and reducing healthcare costs drives the adoption of cardiac POC testing devices across various healthcare settings.

Cardiac POC Testing Devices Market Opportunity: Integration of Connectivity and Data Management Features

An opportunity for market growth in the Cardiac POC Testing Devices market lies in the integration of connectivity and data management features. As healthcare systems transition towards digitalization and interoperability, there is an increasing focus on integrating POCT devices with electronic health records (EHRs) and data management platforms. By incorporating wireless connectivity and cloud-based data storage capabilities, manufacturers can enable seamless transmission of test results, real-time remote monitoring, and integration with patient health records. This not only enhances workflow efficiency for healthcare providers but also supports data-driven decision-making and quality improvement initiatives. Moreover, the integration of connectivity features opens avenues for telemedicine and remote consultation, facilitating access to cardiac care in remote or underserved areas. Thus, enhancing the connectivity and data management capabilities of cardiac POC testing devices presents a strategic opportunity to improve patient care delivery and drive market expansion.

Market Share Analysis: Cardiac Troponin (cTn) Test is the fastest growing segment in the Cardiac POC Testing Devices industry

Among the various products in the Cardiac POC Testing Devices segment, the Cardiac Troponin (cTn) Test emerges as the fastest-growing segment. Cardiac troponin is a highly sensitive and specific biomarker used in the diagnosis of acute myocardial infarction (heart attack). The increasing prevalence of cardiovascular diseases, coupled with the rising demand for rapid and accurate diagnosis in emergency settings, is driving the growth of cardiac troponin testing. Additionally, advancements in technology have led to the development of high-sensitivity cardiac troponin assays, which offer improved sensitivity and faster turnaround times, further fueling market growth. With hospitals and diagnostic laboratories increasingly adopting these POC testing devices to enhance patient care and clinical outcomes, the market for cardiac troponin testing is expected to experience significant expansion in the coming years.

Cardiac POC Testing Devices Market Segmentation

By Product
Cardiac Markers Test
-Cardiac Troponin (cTn) Test
-Myoglobin Test
-Creatine Kinase MB Isoenzyme (CK-MB) Test
-Combinational Test Kits
-Brain Natriuretic Peptide (BNP) Test
Analyzers
By End-User
Hospitals
Diagnostic Laboratories
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Cardiac POC Testing Devices Companies

Abbott Laboratories
ACON Laboratories Inc
Alfa Scientific Designs Inc
American Screening Corp Inc
Bio-Rad Laboratories Inc
Danaher Corp
F. Hoffmann-La Roche Ltd
Nano-Ditech Corp
Nova Biomedical Corp
Siemens Healthineers AG
* List not Exhaustive

Reasons to Buy the Cardiac POC Testing Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Cardiac POC Testing Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Cardiac POC Testing Devices Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Cardiac POC Testing Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Cardiac POC Testing Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Cardiac POC Testing Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Cardiac POC Testing Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Cardiac POC Testing Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Cardiac POC Testing Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Cardiac POC Testing Devices Industry
4.2 Key Market Trends in Cardiac POC Testing Devices Industry
4.3 Potential Opportunities in Cardiac POC Testing Devices Industry
4.4 Key Challenges in Cardiac POC Testing Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Cardiac POC Testing Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Cardiac POC Testing Devices Market Outlook by Segments
7.1 Cardiac POC Testing Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Cardiac Markers Test
-Cardiac Troponin (cTn) Test
-Myoglobin Test
-Creatine Kinase MB Isoenzyme (CK-MB) Test
-Combinational Test Kits
-Brain Natriuretic Peptide (BNP) Test
Analyzers
By End-User
Hospitals
Diagnostic Laboratories
Others
8 North America Cardiac POC Testing Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Cardiac POC Testing Devices Markets in 2024
8.2 North America Cardiac POC Testing Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Cardiac POC Testing Devices Market size Outlook by Segments, 2021-2030
By Product
Cardiac Markers Test
-Cardiac Troponin (cTn) Test
-Myoglobin Test
-Creatine Kinase MB Isoenzyme (CK-MB) Test
-Combinational Test Kits
-Brain Natriuretic Peptide (BNP) Test
Analyzers
By End-User
Hospitals
Diagnostic Laboratories
Others
9 Europe Cardiac POC Testing Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Cardiac POC Testing Devices Markets in 2024
9.2 Europe Cardiac POC Testing Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Cardiac POC Testing Devices Market Size Outlook by Segments, 2021-2030
By Product
Cardiac Markers Test
-Cardiac Troponin (cTn) Test
-Myoglobin Test
-Creatine Kinase MB Isoenzyme (CK-MB) Test
-Combinational Test Kits
-Brain Natriuretic Peptide (BNP) Test
Analyzers
By End-User
Hospitals
Diagnostic Laboratories
Others
10 Asia Pacific Cardiac POC Testing Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Cardiac POC Testing Devices Markets in 2024
10.2 Asia Pacific Cardiac POC Testing Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Cardiac POC Testing Devices Market size Outlook by Segments, 2021-2030
By Product
Cardiac Markers Test
-Cardiac Troponin (cTn) Test
-Myoglobin Test
-Creatine Kinase MB Isoenzyme (CK-MB) Test
-Combinational Test Kits
-Brain Natriuretic Peptide (BNP) Test
Analyzers
By End-User
Hospitals
Diagnostic Laboratories
Others
11 South America Cardiac POC Testing Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Cardiac POC Testing Devices Markets in 2024
11.2 South America Cardiac POC Testing Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Cardiac POC Testing Devices Market size Outlook by Segments, 2021-2030
By Product
Cardiac Markers Test
-Cardiac Troponin (cTn) Test
-Myoglobin Test
-Creatine Kinase MB Isoenzyme (CK-MB) Test
-Combinational Test Kits
-Brain Natriuretic Peptide (BNP) Test
Analyzers
By End-User
Hospitals
Diagnostic Laboratories
Others
12 Middle East and Africa Cardiac POC Testing Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Cardiac POC Testing Devices Markets in 2024
12.2 Middle East and Africa Cardiac POC Testing Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Cardiac POC Testing Devices Market size Outlook by Segments, 2021-2030
By Product
Cardiac Markers Test
-Cardiac Troponin (cTn) Test
-Myoglobin Test
-Creatine Kinase MB Isoenzyme (CK-MB) Test
-Combinational Test Kits
-Brain Natriuretic Peptide (BNP) Test
Analyzers
By End-User
Hospitals
Diagnostic Laboratories
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
ACON Laboratories Inc
Alfa Scientific Designs Inc
American Screening Corp Inc
Bio-Rad Laboratories Inc
Danaher Corp
F. Hoffmann-La Roche Ltd
Nano-Ditech Corp
Nova Biomedical Corp
Siemens Healthineers AG
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Cardiac Markers Test
-Cardiac Troponin (cTn) Test
-Myoglobin Test
-Creatine Kinase MB Isoenzyme (CK-MB) Test
-Combinational Test Kits
-Brain Natriuretic Peptide (BNP) Test
Analyzers
By End-User
Hospitals
Diagnostic Laboratories
Others